On February 11, Eva Nilsagård, a board member of the life science company Addlife, purchased 2,000 class B shares in the company. The shares were acquired at a price of SEK 138.50 per share, amounting to a total transaction value of SEK 277,000.
The transaction was executed on Nasdaq Stockholm. This information is disclosed in the Financial Supervisory Authority's insider registry.

Prior to this purchase, Nilsagård owned 9,568 shares in Addlife, according to the shareholder service Holdings.